Literature DB >> 11566935

Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis.

H D Intengan1, E L Schiffrin.   

Abstract

Remodeling of large and small arteries contributes to the development and complications of hypertension. The focus of this review is some of the mechanisms involved in the remodeling of small arteries in hypertension. In hypertension, changes in small artery structure are basically of 2 kinds: (1) inward eutrophic remodeling, in which outer and lumen diameters are decreased, media/lumen ratio is increased, and cross-sectional area of the media is unaltered; and (2) hypertrophic remodeling, in which the media thickens to encroach on the lumen, resulting in increased media cross-sectional area and media/lumen ratio. Growth, apoptosis, inflammation, and fibrosis contribute to vascular remodeling in hypertension. Apoptosis is gene-regulated cell death, with minimal membrane disruption and inflammation, that counters cell proliferation and fine-tunes developmental growth. Apoptosis has been reported in hypertension to be both increased and decreased in different tissues, including blood vessels. Inflammation, which may be low grade, probably plays an important role in triggering fibrosis in cardiovascular disease and hypertension. Vascular fibrosis entails accumulation of collagen, fibronectin, and other extracellular matrix components in the vessel wall and is an important aspect of extracellular matrix remodeling in hypertension. Associated with this, there may be increases in cell-matrix attachment sites (integrins) and changes in their topographical localization that may modulate arterial structure. Imbalance in matrix metalloproteinase/tissue inhibitors of metalloproteinases may contribute to alteration in collagen turnover and extracellular matrix remodeling. Chronic vasoconstriction may lead to embedding of the contracted vessel structure in a remodeled extracellular matrix, contributing to the inward remodeling of the blood vessel as smooth muscle cells are rearranged around a smaller lumen. The resulting remodeling of small arteries may initially be adaptive, but eventually it becomes maladaptive and compromises organ function, contributing to cardiovascular complications of hypertension.

Entities:  

Mesh:

Year:  2001        PMID: 11566935     DOI: 10.1161/hy09t1.096249

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  254 in total

Review 1.  Intracranial aneurysms: from vessel wall pathology to therapeutic approach.

Authors:  Timo Krings; Daniel M Mandell; Tim-Rasmus Kiehl; Sasikhan Geibprasert; Michael Tymianski; Hortensia Alvarez; Karel G terBrugge; Franz-Josef Hans
Journal:  Nat Rev Neurol       Date:  2011-09-20       Impact factor: 42.937

2.  Aging, metabolic syndrome and the heart.

Authors:  Guarner Veronica; Rubio-Ruiz Maria Esther
Journal:  Aging Dis       Date:  2012-03-13       Impact factor: 6.745

3.  Volume matters: novel roles of the volume-regulated CLC-3 channels in hypertension-induced cerebrovascular remodeling.

Authors:  Dayue Darrel Duan
Journal:  Hypertension       Date:  2010-07-19       Impact factor: 10.190

Review 4.  Skeletal Blood Flow in Bone Repair and Maintenance.

Authors:  Ryan E Tomlinson; Matthew J Silva
Journal:  Bone Res       Date:  2013-12-31       Impact factor: 13.567

Review 5.  Smooth muscle phenotype switching in blast traumatic brain injury-induced cerebral vasospasm.

Authors:  Eric S Hald; Patrick W Alford
Journal:  Transl Stroke Res       Date:  2013-11-07       Impact factor: 6.829

6.  Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1.

Authors:  Kamakshi Sachidanandam; Jim R Hutchinson; Mostafa M Elgebaly; Erin M Mezzetti; Anne M Dorrance; Kouros Motamed; Adviye Ergul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-28       Impact factor: 3.619

7.  Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41.

Authors:  Niranjana Natarajan; Daijiro Hori; Sheila Flavahan; Jochen Steppan; Nicholas A Flavahan; Dan E Berkowitz; Jennifer L Pluznick
Journal:  Physiol Genomics       Date:  2016-09-23       Impact factor: 3.107

Review 8.  The role of angiotensin II in regulating vascular structural and functional changes in hypertension.

Authors:  Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

9.  Circulating mitochondrial DNA and Toll-like receptor 9 are associated with vascular dysfunction in spontaneously hypertensive rats.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Styliani Goulopoulou; Safia Ogbi; Babak Baban; Jennifer C Sullivan; Takayuki Matsumoto; R Clinton Webb
Journal:  Cardiovasc Res       Date:  2015-04-24       Impact factor: 10.787

Review 10.  Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.